Variables | Without MetS | With MetS | P value |
---|---|---|---|
N (%) | 168 (26.6) | 502 (74.9) | - |
Age (years) | 53.39 ± 10.34 | 54.36 ± 10.54 | 0.300 |
Females (n, %) | 101 (60.11) | 259 (51.59) | 0.054 |
Diabetes duration (years) | 5.94 ± 6.35 | 5.81 ± 5.46 | 0.800 |
Body mass index (kg/m2) | 25.96 ± 3.48 | 30.78 ± 4.69 | < 0.001* |
Waist circumference (cm) | 88.59 ± 8.43 | 102.94 ± 8.67 | < 0.001* |
Diastolic blood pressure (mmHg) | 78.77 ± 7.28 | 81.56 ± 8.19 | < 0.001* |
Systolic blood pressure (mmHg) | 122.50 ± 13.92 | 130.94 ± 17.34 | < 0.001* |
Anti hypertensive medications a (n, %) | 68 (40.50) | 200 (39.84) | 0.917 |
Anti-Diabetic Medications (n, %) | Â | Â | 0.470 |
   No medication | 0 (0) | 2 (0.01) |  |
   Glibenclamide | 29 (17.8) | 71 (14.1) |  |
   Metformin | 34 (20.2) | 123 (24.5) |  |
   Glibenclamide & Metformin | 63 (37.5) | 206 (41.0) |  |
Lipid Lowering Agents (n, %) | Â | Â | 0.189 |
   No medication | 103 (61.31) | 271 (53.98) |  |
   Statins | 53 (31.55) | 174 (34.66) |  |
   Fibrates | 4 (2.38) | 30 (5.97) |  |
   Statins & Fibrates | 8 (4.76) | 22 (4.38) |  |
HbA1c (%) | 7.68 ± 1.92 | 8.03 ± 1.77 | 0.130 |
Fasting plasma glucose (mg/dL) | 162.86 ± 58.13 | 166.49 ± 53.23 | 0.445 |
Triglycerides (mg/dL) | 158.21 ± 90.03 | 213.01 ± 118.73 | < 0.001* |
HDL-C (mg/dL) | 48.16 ± 11.26 | 44.23 ± 12.60 | < 0.001* |
LDL-C (mg/dL) | 115.59 ± 37.77 | 111.73 ± 36.05 | 0.236 |
Total cholesterol (mg/dL) | 195.08 ± 44.84 | 197.29 ± 45.34 | 0.583 |
Alanine aminotransferase (U/L) | 27.30 ± 15.23 | 31.76 ± 18.74 | 0.006* |
Aspartate aminotransferase (U/L) | 21.53 ± 9.58 | 24.17 ± 13.84 | 0.007* |
Alkaline phosphatase (U/L) | 148.44 ± 92.83 | 151.95 ± 77.01 | 0.653 |